EUVIMEDOpdag EUVIMED
Leserbrief

Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After SVR . Authors' Reply

Yu-Sheng Lin, Yun-Yu Chen, Teng-Yu Lee iD

Alimentary Pharmacology & Therapeutics · 2026-05 · 63 (10) · 1439-1440

DOI: 10.1111/apt.70610 ↗

At a glance

Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-03-07. Written by Yu-Sheng Lin and 2 co-authors. Institution: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. 9 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Subjects

Author keywords

genetic risk scorehepatitis Chepatocellular carcinoma

Authors and institutions

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, Chung Hsing University, Taichung, Taiwan.
  • Cardiovascular Center, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
  • School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

ORCID profiles: Teng-Yu Lee

Cite

APA

Lin, Y. S., Chen, Y. Y., & Lee, T. Y. (2026). Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After SVR . Authors' Reply. Alimentary Pharmacology & Therapeutics, 63(10), 1439-1440. https://doi.org/10.1111/apt.70610

Vancouver

Lin YS, Chen YY, Lee TY. Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After SVR . Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;63(10):1439-1440. doi:10.1111/apt.70610

BibTeX
@article{Lin2026,
  author = {Lin, Yu-Sheng and Chen, Yun-Yu and Lee, Teng-Yu},
  title = {Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After SVR . Authors' Reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {10},
  pages = {1439--1440},
  doi = {10.1111/apt.70610}
}
Start for free →